1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3
(
- Contribution to journal › Article
- 2019
-
Mark
Using global team science to identify genetic parkinson's disease worldwide
(
- Contribution to journal › Article
- 2017
-
Mark
Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder
(
- Contribution to journal › Letter
-
Mark
Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism
(
- Contribution to journal › Article
- 2016
-
Mark
Heterozygous PINK1 p.G411S mutation increases risk for Parkinson's disease (PD)
2016) 20th International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 31(Suppl. S2). p.282-282(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.
(
- Contribution to journal › Article
-
Mark
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Alpha-Synuclein Repeat Variants and Survival in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
(
- Contribution to journal › Article
- 2013
-
Mark
Found in transcription : accurate Parkinson's disease classification in peripheral blood
(
- Contribution to journal › Article